Sarcouncil Journal of Internal Medicine and Public Health
Sarcouncil Journal of Internal Medicine and Public Health
An Open access peer reviewed international Journal
Publication Frequency- Bi-Monthly
Publisher Name-SARC Publisher
ISSN Online- 2945-3674
Country of origin-PHILIPPINES
Impact Factor- 3.7
Language- Multilingual
Keywords
- Primary Health Care; Sexual Health; General Medicine; Oral Health; Health Informatics; Family Practice; Mental Health; Health Education; Emergency Care; District Health Care; Rural Health Care; Health Promotion etc.
Editors

Dr Hazim Abdul-Rahman
Associate Editor
Sarcouncil Journal of Applied Sciences

Entessar Al Jbawi
Associate Editor
Sarcouncil Journal of Multidisciplinary

Rishabh Rajesh Shanbhag
Associate Editor
Sarcouncil Journal of Engineering and Computer Sciences

Dr Md. Rezowan ur Rahman
Associate Editor
Sarcouncil Journal of Biomedical Sciences

Dr Ifeoma Christy
Associate Editor
Sarcouncil Journal of Entrepreneurship And Business Management
Antitumor Effects of Dihydromyricetin and Bevacizumab on SKOV-3 Ovarian Cancer Cell Line
Keywords: Dihydromyricetin, Bevacizumab, SKOV-3, Anti-cancer effects, MTT, RT-PCR Analysis
Abstract: Introduction: Ovarian cancer is the deadliest gynecological malignancy, usually not detected until the late stages. In vitro cell culture used for studies such as the study of interactions of drugs. Dihydromyricetin is a key ingredient in many healthy foods or beverages. It has an excellent safety profile for human. Material-Method: SKOV-3 cells were cultured in RPMI medium with 100 units/mL-100 ?g/mL of penicillin-streptomycin and 10% fetal bovine serum in a CO2 incubator. After incubation for 3 h at 37°C with 5% CO2, the media was removed and 0.1 mL of DMSO was added. The plates were read at 570 nm in the spectrophotometer. The MTT assay was repeated at least three times independently. Following this procedure, RT-PCR was performed. Results: SKOV-3 cells were treated with different concentrations of DHM. DHM was found to be cytotoxic to the SKOV-3 cell line in a time- and concentration-dependent manner. SKOV-3 cells were treated with different concentrations of BEV. Cell viability was decreased at the different concentrations. To evaluate the cytotoxic effects of DHM and BEV together on the SKOV-3 cell line, cells were treated with a combination of IC50 concentrations of DHM and BEV. According to combination results, DHM + BEV treatment was found to be more cytotoxic to SKOV-3 cells than treatment with DHM or BEV alone. Conclusion: In our study, the combined effects of two anti-cancer agents on ovarian cancer cell lines were investigated. It has been determined that the effect of the agents in the combined treatment is greater than that of the agents alone
Author
- Ozlem Ozgur Gursoy
- M.D
- Eskisehir Acibadem Hospital; Obstetrics and Gynecology Clinic; Eskisehir; Turkey
- Hulusi Goktug Gurer
- M.D
- Eskisehir Acibadem Hospital; Obstetrics and Gynecology Clinic; Eskisehir Turkey
- Ceren Yildiz ErenM.D
- Eskisehir Acibadem Hospital; Obstetrics and Gynecology Clinic; Eskisehir; Turkey
- Ay?e Tansu Koparal Professor
- Anadolu University; Yunus Emre Vocational School of Health Services; Department of Medical Services and Techniques; Eskisehir Turkey
- Sinem Daba?o?lu
- Eskisehir Technical University; Institute of Graduate Programs; Department of Biology; Eskisehir Turkey.